UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Journal of clinical oncology, 2023-04, Vol.41 (10), p.1795-1808

2023

Volltextzugriff (PDF)

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2672-2685

1998

Volltextzugriff (PDF)

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

Journal of clinical oncology, 1997-07, Vol.15 (7), p.2483-2493

1997

Volltextzugriff (PDF)

Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial

Journal of clinical oncology, 2013-04, Vol.31 (10), p.1341-1347

2013

Volltextzugriff (PDF)

Influence of Biologic Markers on the Outcome of Hodgkin's Lymphoma: A Study by the Spanish Hodgkin’s Lymphoma Study Group

Journal of clinical oncology, 2004-05, Vol.22 (9), p.1664-1673

2004

Volltextzugriff (PDF)

Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1931-1939

1998

Volltextzugriff (PDF)

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

Journal of clinical oncology, 1994-10, Vol.12 (10), p.2078-2085

1994

Volltextzugriff (PDF)

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3339-3351, Article 3339

2023

Volltextzugriff (PDF)

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

Journal of clinical oncology, 2024-06, Vol.42 (18), p.2149

2024

Volltextzugriff (PDF)

Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1462-1469

2009

Volltextzugriff (PDF)

Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

Journal of clinical oncology, 1996-01, Vol.14 (1), p.46-51

1996

Volltextzugriff (PDF)

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Journal of clinical oncology, 2024-09

2024

Volltextzugriff (PDF)

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)

Journal of clinical oncology, 2020-01, Vol.38 (3), p.203-213

2020

Volltextzugriff (PDF)

Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium

Journal of clinical oncology, 2000-09, Vol.18 (18), p.3247-3255

2000

Volltextzugriff (PDF)

Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study

Journal of clinical oncology, 1988-06, Vol.6 (6), p.947-954

1988

Volltextzugriff (PDF)

Subgroup analysis of GEICAM 9906 trial comparing six cycles of FE 90 C (FEC) to four cycles of FE 90 C followed by 8 weekly paclitaxel administrations (FECP): Relevance of HER2 and hormonal status (HR)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.10598-10598

2007

Volltextzugriff (PDF)

Malignant pericardial effusion treated with IFN alpha 2b

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.2595-2595

2005

Volltextzugriff (PDF)

HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in operable breast cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.9569-9569

2005

Volltextzugriff (PDF)

Evaluation of clinical use of darbepoetin alfa in patients with chemotherapy-induced anemia

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e20585-e20585

2009

Volltextzugriff (PDF)

Clinical development of huARH460–16–2: A therapeutic antibody targeting the CD44 cancer stem cell antigen on high-incidence adenocarcinomas

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.14581-14581

2008

Volltextzugriff (PDF)

5,10 methylenetetrahydrofolic acid with fluorouracil as treatment for advanced breast cancer in patients who failed prior treatment with anthracyclines and taxanes: A phase II study

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.1136-1136

2008

Volltextzugriff (PDF)

Human chimeric anti-CD44 antibody ARH460–16–2 binds leukemic cells and malignant plasma cells

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.14010-14010

2008

Volltextzugriff (PDF)

Therapeutic monoclonal antibodies target phenotypically-differing human breast cancer

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.13510-13510

2007

Volltextzugriff (PDF)

Every-other week capecitabine (C7) combinations: An active and well tolerated treatment in heavily pretreated patients (p) with advanced solid tumours

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10649-10649

2006

Volltextzugriff (PDF)

1 – 25 von 638

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(638)
Mit Volltextzugriff
(614)

Publikationsform

Artikel
(638)

Sprache

Englisch
(638)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(61)
Oncology
(61)
Science & Technology
(61)
Humans
(53)
Female
(39)
Middle Aged
(36)
Aged
(33)
Male
(32)
Adult
(31)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(23)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Tumors
(15)
Aged, 80 And Over
(13)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(13)
Original Reports
(13)
Treatment Outcome
(13)
Disease-Free Survival
(11)
Adolescent
(10)
Breast Neoplasms - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

Fluorouracil, Leucovorin, and Irinotecan Plus Either Sunitinib or Placebo in Metastatic Colorectal Cancer: A Randomized, Phase III Trial

Influence of Biologic Markers on the Outcome of Hodgkin's Lymphoma: A Study by the Spanish Hodgkin’s Lymphoma Study Group

Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow Cytometry

Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)

Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium

Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study

Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma : AnOpen-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas

Subgroup analysis of GEICAM 9906 trial comparing six cycles of FE 90 C (FEC) to four cycles of FE 90 C followed by 8 weekly paclitaxel administrations (FECP): Relevance of HER2 and hormonal status (HR)

Malignant pericardial effusion treated with IFN alpha 2b

HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in operable breast cancer

Evaluation of clinical use of darbepoetin alfa in patients with chemotherapy-induced anemia

Clinical development of huARH460–16–2: A therapeutic antibody targeting the CD44 cancer stem cell antigen on high-incidence adenocarcinomas

5,10 methylenetetrahydrofolic acid with fluorouracil as treatment for advanced breast cancer in patients who failed prior treatment with anthracyclines and taxanes: A phase II study

Human chimeric anti-CD44 antibody ARH460–16–2 binds leukemic cells and malignant plasma cells

Therapeutic monoclonal antibodies target phenotypically-differing human breast cancer

Every-other week capecitabine (C7) combinations: An active and well tolerated treatment in heavily pretreated patients (p) with advanced solid tumours

Aktive Filter

Suchergebnisse filtern